Financials

  • Market Capitalization 1.77 B
  • Employee 130
  • Founded 2019
  • CEO N/A
  • Website www.septerna.com
  • Headquarter Delaware, United States
  • FIGI BBG014WY1V28
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-63.19
Fiyat/satışlar oranı
15.2

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2070
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.58 USD-3.29%-7.77%-5.26%+92.41%1.82 B USD
2079
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.38 USD+1.20%+3.36%+11.55%-26.36%1.81 B USD
2094
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.68 USD-1.48%+1.85%+19.74%-7.58%1.78 B USD
2104
GHRS
GH Research PLC - Ordinary Shares
27.25 USD-2.47%-3.47%-3.27%+92.44%1.69 B USD